These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 8467365
1. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat. Kappelle AC, Bravenboer B, van Buren T, Traber J, Erkelens DW, Gispen WH. Br J Pharmacol; 1993 Mar; 108(3):780-5. PubMed ID: 8467365 [Abstract] [Full Text] [Related]
2. Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. Kappelle AC, Biessels G, Bravenboer B, van Buren T, Traber J, de Wildt DJ, Gispen WH. Br J Pharmacol; 1994 Mar; 111(3):887-93. PubMed ID: 8019766 [Abstract] [Full Text] [Related]
3. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Li F, Szabó C, Pacher P, Southan GJ, Abatan OI, Charniauskaya T, Stevens MJ, Obrosova IG. Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348 [Abstract] [Full Text] [Related]
4. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. Biessels GJ, ter Laak MP, Kamal A, Gispen WH. Brain Res; 2005 Feb 21; 1035(1):86-93. PubMed ID: 15713280 [Abstract] [Full Text] [Related]
5. Failure of nimodipine to prevent or correct the long-term nerve conduction defect and increased neuronal Ca(2+)-currents in the diabetic BB/W-rat. Ristic H, Wiley JW, Hall KE, Sima AA. Diabetes Res Clin Pract; 1996 May 21; 32(3):135-40. PubMed ID: 8858201 [Abstract] [Full Text] [Related]
6. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Bravenboer B, Kappelle AC, Hamers FP, van Buren T, Erkelens DW, Gispen WH. Diabetologia; 1992 Sep 21; 35(9):813-7. PubMed ID: 1397775 [Abstract] [Full Text] [Related]
8. Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats. Aggarwal M, Singh J, Sood S, Arora B. Methods Find Exp Clin Pharmacol; 2001 Apr 21; 23(3):131-4. PubMed ID: 11523311 [Abstract] [Full Text] [Related]
9. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen. Cameron NE, Cotter MA, Dines KC, Robertson S, Cox D. Br J Pharmacol; 1993 Aug 21; 109(4):972-9. PubMed ID: 8401950 [Abstract] [Full Text] [Related]
10. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Cameron NE, Dines KC, Cotter MA. Diabetologia; 1994 Dec 21; 37(12):1209-15. PubMed ID: 7895950 [Abstract] [Full Text] [Related]
11. Effects of nimodipine on sciatic nerve blood flow and vasa nervorum responsiveness in the diabetic rat. Kappelle AC, Biessels GJ, Van Buren T, Erkelens DW, De Wildt DJ, Gispen WH. Eur J Pharmacol; 1993 Nov 30; 250(1):43-9. PubMed ID: 8119324 [Abstract] [Full Text] [Related]
12. Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats. Bíró K, Jednákovits A, Kukorelli T, Hegedüs E, Korányi L. Brain Res Bull; 1997 Nov 30; 44(3):259-63. PubMed ID: 9323440 [Abstract] [Full Text] [Related]
13. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost. Cotter MA, Dines KC, Cameron NE. Naunyn Schmiedebergs Arch Pharmacol; 1993 May 30; 347(5):534-40. PubMed ID: 7686634 [Abstract] [Full Text] [Related]
14. TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats. Mizisin AP, Steinhardt RC, O'Brien JS, Calcutt NA. J Neuropathol Exp Neurol; 2001 Oct 30; 60(10):953-60. PubMed ID: 11589426 [Abstract] [Full Text] [Related]
15. Effect of honey and insulin treatment on oxidative stress and nerve conduction in an experimental model of diabetic neuropathy Wistar rats. Sirisha A, Gaur GS, Pal P, Bobby Z, Balakumar B, Pal GK. PLoS One; 2021 Oct 30; 16(1):e0245395. PubMed ID: 33449943 [Abstract] [Full Text] [Related]
16. Comparison of short-term effects of insulin and essential fatty acids on the slowed nerve conduction of streptozotocin diabetes in rats. Julu PO, Mutamba A. J Neurol Sci; 1991 Nov 30; 106(1):56-9. PubMed ID: 1663993 [Abstract] [Full Text] [Related]
17. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima E, Sakamoto N. J Pharmacol Exp Ther; 1996 Jan 30; 276(1):49-55. PubMed ID: 8558455 [Abstract] [Full Text] [Related]
18. Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats. Van der Zee CE, Van der Hoop RG, Gispen WH. Diabetes; 1989 Feb 30; 38(2):225-30. PubMed ID: 2536628 [Abstract] [Full Text] [Related]
19. Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Dines KC, Cotter MA, Cameron NE. Diabetologia; 1993 Nov 30; 36(11):1132-8. PubMed ID: 8270127 [Abstract] [Full Text] [Related]
20. The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats. Shutov L, Kruglikov I, Gryshchenko O, Khomula E, Viatchenko-Karpinski V, Belan P, Voitenko N. Cell Mol Neurobiol; 2006 Nov 30; 26(7-8):1541-57. PubMed ID: 16838100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]